Biotinylated SARS-CoV-2 Nucleocapsid Protein

• Description:

  Biotinylated SARS-CoV-2 Nucleocapsid Protein_x000D_ Catalog number: B2010502_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 25 ug_x000D_ Molecular Weight or Concentration: 47 kDa_x000D_ Supplied as: Liquid Solution_x000D_ Applications: molecular component of serological and antigenic assays for SARS-CoV-2_x000D_ Storage: -20℃_x000D_ Keywords: Nucleoprotein, N protein, biotin-nucleoprotein_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ Download SARS-CoV-2 Brochure_x000D_ _x000D_ References:_x000D_ 1: Yoshimoto FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2_x000D_ (SARS CoV-2 or n-COV19), the Cause of COVID-19. Protein J. 2020_x000D_ Jun;39(3):198-216._x000D_ _x000D_ 2: Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi_x000D_ PY. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020 Oct_x000D_ 6;33(1):108234._x000D_ _x000D_ 3: Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, Pan P, Wu K, Wu J. SARS-CoV-2_x000D_ Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β_x000D_ Production. Viruses. 2020 Dec 30;13(1):47._x000D_ _x000D_ 4: Ahmed SF, Quadeer AA, McKay MR. Preliminary Identification of Potential_x000D_ Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV_x000D_ Immunological Studies. Viruses. 2020 Feb 25;12(3):254._x000D_ _x000D_ 5: Mu J, Xu J, Zhang L, Shu T, Wu D, Huang M, Ren Y, Li X, Geng Q, Xu Y, Qiu Y,_x000D_ Zhou X. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of_x000D_ RNA interference in cells. Sci China Life Sci. 2020 Sep;63(9):1413-1416._x000D_ _x000D_ 6: Dutta NK, Mazumdar K, Gordy JT. The Nucleocapsid Protein of SARS-CoV-2: a_x000D_ Target for Vaccine Development. J Virol. 2020 Jun 16;94(13):e00647-20._x000D_ _x000D_ 7: Oliveira SC, de Magalhães MTQ, Homan EJ. Immunoinformatic Analysis of SARS-_x000D_ CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets. Front_x000D_ Immunol. 2020 Oct 28;11:587615._x000D_ _x000D_ 8: Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou JJ, Li N, Guo Y, Li X, Shen X,_x000D_ Zhang Z, Shu F, Huang W, Li Y, Zhang Z, Chen RA, Wu YJ, Peng SM, Huang M, Xie_x000D_ WJ, Cai QH, Hou FH, Chen W, Xiao L, Shen Y. Isolation of SARS-CoV-2-related_x000D_ coronavirus from Malayan pangolins. Nature. 2020 Jul;583(7815):286-289._x000D_ _x000D_ 9: Li JY, Liao CH, Wang Q, Tan YJ, Luo R, Qiu Y, Ge XY. The ORF6, ORF8 and_x000D_ nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway._x000D_ Virus Res. 2020 Sep;286:198074._x000D_ 10: Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS-CoV-2, the_x000D_ pandemic coronavirus: Molecular and structural insights. J Basic Microbiol. 2021_x000D_ Mar;61(3):180-202. _x000D_ _x000D_ Products Related to Biotinylated SARS-CoV-2 Nucleocapsid Protein : SARS-CoV-2

• Short Description:

  Catalog Number: B2010502 (25 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5